Market Tracker

02/23 5:16pm ET

Oramed Pharmaceuticals Inc (NASDAQ:ORMP)

6.18
Delayed Data
As of 3:59pm ET
 -0.13 / -2.06%
Today’s Change
5.70
Today|||52-Week Range
10.51
+0.98%
Year-to-Date
No recent news for Oramed Pharmaceuticals Inc.

Today’s Trading

Previous close6.31
Today’s open6.30
Day’s range6.13 - 6.32
Volume18,711
Average volume (3 months)30,759
Market cap$83.8M
Dividend yield--
Data as of 3:59pm ET, 02/23/2017

Growth & Valuation

Earnings growth (last year)-29.85%
Earnings growth (this year)--
Earnings growth (next 5 years)--
Revenue growth (last year)--
P/E ratioNM
Price/Sales142.00
Price/Book3.18

Competitors

 Today’s
change
Today’s
% change
NOVNNovan Inc-0.34-6.46%
ALIMAlimera Sciences Inc-0.05-3.91%
CASICASI Pharmaceuticals...+0.04+2.84%
SBPHSpring Bank Pharmace...+0.38+4.35%
Data as of 4:00pm ET, 02/23/2017

Financials

Last reporting dateNovember 23, 2016
EPS forecast (this quarter)-$0.19
Annual revenue (last year)$641.0K
Annual profit (last year)-$11.0M
Net profit margin-1,710.45%

Profile

Sector
Health Technology
Industry
Pharmaceuticals: Other
President, Chief Executive Officer &
Director
Nadav Kidron
Chief Operating Officer &
VP-Business Development
Joshua Hexter
Corporate headquarters
Jerusalem, Jerusalem

Forecasts